Otsuka Novel Products GmbH focuses on fighting tuberculosis through innovative research and development, equitable access to medicines, collaborations, and capacity building programmes that strengthen the quality and delivery of care.

Otsuka Novel Products GmbH

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Metric
Company Name	Otsuka Novel Products GmbH	Otsuka Holdings Co., Ltd.
Symbol		4.58K
MSH ID	COM:OTSUKA-ONPG	COM:OTSUKA
Market	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare
Industry	Pharmaceuticals	Drug Manufacturers - General
Country	DE	JP
Stage
Employee Count		34.39K
Website	otsuka-onpg.com	otsuka.com
LinkedIn
Founders

Metric
Market Cap		25.24B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		13.10B
Revenue (LTM)
Revenue (NTM)
Gross Profit		9.13B
EBITDA		2.53B
Operating Income		1.90B
Net Income		789.23M
EPS		1.45
Diluted EPS		1.45
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.71
Operating Profit Margin		0.15
EBITDA Margin		0.19
Net Profit Margin		0.07
Return on Equity		0.06
Return on Assets		0.04
Return on Capital Employed		0.11

OTSU

COM:OTSUKA-ONPG

Otsuka Novel Products GmbH

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		16.87
P/B Ratio		1.25
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		2.26
EV Multiple		11.34

Metric
Days Sales Outstanding		94.09
Days Payables Outstanding		115.26
Days Inventory Outstanding		169.37
Operating Cycle		259.01
Cash Conversion Cycle		136.71
Asset Turnover		0.61

Metric
Operating Cash Flow		1.84B
Free Cash Flow		1.09B
Cash Flow to Debt		1.80
Operating Cash Flow/Sales		0.14
Free Cash Flow Yield		0.04

Metric
Cash & Equivalents		3.33B
Accounts Receivable		-206.38M
Inventory		1.62B
Goodwill		2.46B
Debt to Capitalization		0.07
Debt to Assets		0.05
Current Ratio		2.14
Quick Ratio		1.66

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue		0.15
SG&A to Revenue		0.40